Anthony Quinn, Aeglea BioTherapeutics' departing CEO

Ae­glea re­places CEO as com­pa­ny is set to cut more em­ploy­ees, change strat­e­gy

Many com­pa­nies have been re­cent vic­tims of the bud­get axe. And an Austin, TX biotech is no ex­cep­tion.

Ae­glea Bio­Ther­a­peu­tics an­nounced ear­li­er this week that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.